1891 – 1900 of 2191
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
(
- Contribution to journal › Article
-
Mark
Mutated V-H genes and preferential V(H)3-21 use define new subsets of mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro.
(
- Contribution to journal › Article
-
Mark
More efficient mobilisation of peripheral blood stem cells with HiDAC plus AMSA plus G-CSF than with mini-ICE plus G-CSF in patients with AML
(
- Contribution to journal › Article
-
Mark
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
(
- Contribution to journal › Article
-
Mark
Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins.
(
- Contribution to journal › Article
-
Mark
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant
(
- Contribution to journal › Article
-
Mark
Third and Fourth Workshops of the European paediatric network for haemophilia management.
(
- Contribution to journal › Article
-
Mark
Factor VI359T: a novel mutation associated with thrombosis and resistance to activated protein C
(
- Contribution to journal › Article
-
Mark
Central venous lines in haemophilia.
(
- Contribution to journal › Article